Cardiology research is complex and ever evolving. How does one stay on top of the information overload of clinical trends, treatment guidelines, and research? As the expression goes, it can be like drinking from a firehose! And with over 350 Cardiology journals to choose from, how do you select those most relevant to you? Hereby we have presented the top 15 journals based on … [Read more...] about TOP 15 CARDIOLOGY JOURNALS
Interventional cardiology
TOP 15 CARDIOLOGY CONFERENCES FOR 2020
Healthcare is complex and ever evolving. We are all striving to remain current, and we must meet CME requirements. With conferences happening on a weekly basis all around the world, how does one choose how to invest one’s CME budget? Here is our curated list (in order, by date) of the top 15 cardiology conferences happening this year, so that you can plan your travel and budget … [Read more...] about TOP 15 CARDIOLOGY CONFERENCES FOR 2020
Renin-angiotensin system inhibitors improve TAVR prognosis
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace narrowed aortic valves that fail to properly open. Following this procedure, however, left ventricular (LV) hypertrophy and myocardial fibrosis persist and are linked to worse prognosis. Renin-angiotensin system (RAS) inhibition can protect against these risks and in response to … [Read more...] about Renin-angiotensin system inhibitors improve TAVR prognosis
AHA 2019: What you need to know
American Heart Association Scientific Sessions, November 16–18, 2019 (Philadelphia, USA) The AHA Scientific Sessions event is the annual meeting of the American Heart Association, considered the number one cardiovascular research and education meeting in the world. ISCHEMIA1: The results of this trial in 5179 higher-risk patients with stable ischemic heart disease … [Read more...] about AHA 2019: What you need to know
Global consensus on CTO-PCI best practices
A chronic total occlusion (CTO) is the complete obstruction of a coronary artery, presenting a Thrombolysis In Myocardial Infarction (TIMI) 0 flow and an occlusion duration of at least 3 months. With the advancement of equipment, techniques and key indicators, the success rates of CTO percutaneous coronary intervention (PCI) have greatly improved. During CTO-PCI meetings in … [Read more...] about Global consensus on CTO-PCI best practices